China bans imports of Illumina's gene sequencers right after Trump tariff action

Key Points

  • China announced a ban on imports of genetic sequencers from U.S. medical equipment maker Illumina, effective from March 4.
  • Illumina's stock fell over 4% before the bell on Tuesday, reflecting investor concerns over the impact of the ban.
  • The ban is part of China's response to additional U.S. tariffs, following Illumina's inclusion on China's "unreliable entity" list in February.
  • Illumina stated it would continue to serve its customers in China and is assessing the impact of the ban on its operations.

Summary

China has imposed a ban on imports of genetic sequencers from Illumina, a U.S. medical equipment company, in retaliation to the U.S. imposing additional tariffs on Chinese goods. This decision was made public just minutes after the new U.S. tariffs took effect. Illumina, which saw its stock drop by over 4% before the market opened, has been under scrutiny in China since being added to the country's "unreliable entity" list in February. The ban, effective from March 4, comes at a time when Illumina's sales in Greater China had already decreased by nearly 20% last year due to competition from local firms like MGI and BGI. These Chinese companies saw their stock prices surge following the announcement, with MGI Tech's shares hitting the daily limit. Illumina has expressed its commitment to continue serving its Chinese customers while assessing the full impact of the ban. This move by China is part of a broader set of retaliatory measures against U.S. companies, including investigations into other American firms like PVH Corp and Google.

yahoo
March 4, 2025
Stocks
Read article

Related news